Computational assessment of MCM2 transcriptional expression and identification of the prognostic biomarker for human breast cancer-Reference-Cited by-同舟云学术

Computational assessment of MCM2 transcriptional expression and identification of the prognostic biomarker for human breast cancer

Published:2020-10 Issue:10 Volume:6 Page:e05087
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Samad Abdus,Haque Farhana,Nain Zulkar,Alam Rahat^ORCID,Al Noman Md Abdullah,Rahman Molla Mohammad Habibur,Hossen Md Saddam,Islam Md Raquibul,Khan Md Iqbal^ORCID,Ahammad Foysal^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference54 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Canc.,2015

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

3. Cell cycle, CDKs and cancer: a changing paradigm;Malumbres;Nat. Rev. Canc.,2009

4. Targeting the cell cycle in breast cancer: towards the next phase;Thu;Cell Cycle,2018

5. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer;Gonzalez;J. Clin. Oncol.,2003

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pixantrone as a novel MCM2 inhibitor for ovarian cancer treatment;European Journal of Pharmacology;2024-09

2. EFFECT of CURCUMIN on BREAST CANCER CELLS THROUGH miR-145-5p AND ITS TARGET GENES;Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi;2024-06-04

3. Unveiling promising breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental verification;BMC Cancer;2024-01-31

4. Multi-omics prognostic signatures of IPO11 mRNA expression and clinical outcomes in colorectal cancer using bioinformatics approaches;Health Information Science and Systems;2023-11-27

5. Identification of natural antiviral drug candidates against Tilapia Lake Virus: Computational drug design approaches;PLOS ONE;2023-11-08